Novo Nordisk A/S (B Shares) ADRhedged
NVOH
1 hedge funds and large institutions have $12.2K invested in Novo Nordisk A/S (B Shares) ADRhedged in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
39.29% less ownership
Funds ownership: 40.97% → 1.68% (-39%)
50% less funds holding
Funds holding: 2 → 1 (-1)
96% less capital invested
Capital invested by funds: $328K → $12.2K (-$316K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
New York
|
-$315K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $12.2K | – | – | – |
|
|
GS
2
GTS Securities
New York
| – | -$315K | -7,858 | Closed |
|
NVOH Hedge Fund Activity: Q2 2025 in Review
1 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk A/S (B Shares) ADRhedged (NVOH) for Q2 2025, worth a combined $12.2K — down 96% from $328K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NVOH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was GTS Securities, exiting entirely with an estimated $315K sold.
- 1 institutional investor held Novo Nordisk A/S (B Shares) ADRhedged (NVOH) as of Q2 2025, down from 2 in Q1 2025.
- Funds reported $12.2K of Novo Nordisk A/S (B Shares) ADRhedged stock for Q2 2025, down 96% quarter-over-quarter.
- 0 funds opened new Novo Nordisk A/S (B Shares) ADRhedged positions in Q2 2025 and 1 closed out, a net change of -1 holder.
- The largest Novo Nordisk A/S (B Shares) ADRhedged seller in Q2 2025 was GTS Securities, an estimated $315K sold.
Based on aggregated 13F filings for Q2 2025.